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INTRODUCTION
Microdeletion within 22q11 is associated with a wide vari-
ety of birth defects. The acronym CATCH 22 (1) has been
introduced to indicate the common forms of defects, name-
ly, cardiac defect, abnormal facies, thymic hypoplasia, cleft
palate, and hypocalcemia.
Velocardiofacial syndrome (2), conotruncal congenital
heart disease (3), and DiGeorge syndrome (DGS) (4) lie at
the end of the clinical spectrum with severe manifestations.
Cardiac involvement is a prominent feature. Most of the
patients were reported to have  conotruncal heart defect (5).
This haploinsufficiency of 22q11 is a relatively frequent
cause of birth defect (6). This condition is the second most
frequent chromosomal anomaly associated with congenital
heart disease. Familial cases with a high phenotypic variabil-
ity among individuals have been reported, but most cases
are sporadic. Fluorescence in situ hybridization (FISH) using
a unique sequence DNA probe is an efficient, quick, and
direct method for the detection of 22q11 microdeletions (7)
and is now a widely used procedure in many laboratories (8,
9). However, only a few cases of prenatal diagnosis have been
reported. We report two cases of tetralogy of Fallot in which
microdeletion of chromosome 22q11 was diagnosed by FISH
prenatally.
CASE REPORTS
Fetal blood sample in Case 1 and amniotic fluid in Case 2
were obtained for karyotyping and FISH. Cells harvested
from cultures of phytohemagglutin-stimulated lymphocytes
were spread onto slides for the production of G-banded chro-
mosomes. FISH of metaphase chromosomes using the LSI
DiGeorge/VCFS Region Dual Color Probe (Vysis) for the
DGS chromosome region was carried out according to Pinkel
et al. (10).
Case 1
A 29-yr-old Gravida 2 Para 1 woman underwent fetal
echocardiography because her previous baby died of sepsis
complicating congenital heart disease at 7 days of age. Fetal
echocardiography showed tetralogy of Fallot (TOF), severe
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Prenatal Diagnosis of Tetralogy of Fallot Associated with
Chromosome 22q11 Deletion
Microdeletion of 22q11 is responsible for DiGeorge syndrome, velocardiofacial
syndrome, congenital conotruncal heart defects, and related disorders. We
report our experiences on prenatal diagnosis by fluorescence in situ hybridiza-
tion (FISH) for 22q11 deletion in two fetuses with tetralogy of fallot. Karyotyping
and FISH of the parents revealed that one fetus inherited the disease from
maternal microdeletion. These findings suggest the importance of performing
FISH in pregnancies with prenatally detected tetralogy of Fallot.
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hypoplasia of pulmonary arteries, right aortic arch with aber-
rant left subclavian artery arising from the descending aorta
at 23 weeks of gestation. The possibility of CATCH 22 syn-
drome was considered because of her previous history and
its strong association with TOF. A fetal blood sample was
obtained for karyotyping and FISH for CATCH 22, which
revealed 46,XX karyotype with a 22q11 deletion (Fig. 1).
The parental karyotypings were normal. However, the moth-
er was found to be a carrier of the deletion by FISH on lym-
phocytes in metaphase. She did not show unusual faces or
known cardiac abnormality. The parents decided to termi-
nate the pregnancy. The autopsy confirmed the diagnosis by
fetal echocardiography, tetralogy of Fallot with normal appear-
ing thymus.
Case 2
A 37-yr-old woman was referred for fetal echocardiogra-
phy because of abnormal cardiac axis deviated to the left at
fetal ultrasound screening. She had a normal female baby.
Amniocentesis for fetal karyotyping was performed because
of the old maternal age at 15 weeks of gestation at a local
clinic. The result was normal. Fetal echocardiography at 21
weeks of gestation revealed tetralogy of Fallot with severe
pulmonary stenosis. The fetal thymus was visible in front of
the great arterial trunk. The parents decided to terminate
the pregnancy. The FISH study from amniotic fluid drawn
before termination revealed the 22q11 microdeletion. Autop-
sy was refused. Parents had normal karyotype without 22q11
deletion.
DISCUSSION
Chromosome 22q11 deletion causes a contiguous gene
syndrome that includes DiGeorge syndrome (DGS) (4),
velocardiofacial syndrome (VCFS) (2), and conotruncal anoma-
ly face syndrome (CAFS) (3). Wilson et al. acronymed the
common forms of defects associated with chromosome 22q11
deletion as CATCH 22 syndrome. The most severely affect-
ed patients have serious life threatening heart defects. The
least severely affected patients have only mild facial anoma-
lies and some developmental delay without cardiac defects
(11). However, most of the patients with chromosome 22q11
microdeletion who have survived infancy were mildly to mod-
erately retarded (12). 
The estimated incidence of deletion of chromosome 22q11
is 1 in 4,000 live births (13). Cardiovascular abnormalities
have been reported in 83% of those with 22q11 deletion
(14). This condition is the second most frequent chromoso-
mal anomaly associated with congenital heart disease, next
to Down syndrome. Congenital heart defects characteristi-
cally involve the conotruncal region, tetralogy of Fallot
(TOF), interrupted aortic arch, and truncus arteriosus being
the most common lesion. TOF is the most common cyanot-
ic congenital heart disease, occurring in approximately 10%
of infants with congenital heart disease. The improvements in
routine ultrasound techniques are expected to increase dra-
matically the number of cases with prenatally detected car-
diac defects (15). Prenatal diagnosis of tetralogy of Fallot
aids parental counseling and enables the early inhibition of
optional treatment at a pediatric cardiac center, which may
further improve treatment outcomes (16).
Chromosome 22 microdeletion occurs de novo in most
cases, with only 8% being inherited (13). When one of the
parents carries the deletion, either symptomatic or not, the
fetus has a 50% risk of inheriting the abnormality. Thus,
parental screening is necessary to identify the parents who
have a 50% risk of affected offspring. For familial cases, pre-
natal genetic diagnosis should be offered. Preimplantation
genetic diagnosis with in vitro fertilization can be considered
to prevent termination of further affected pregnancy since
FISH in a single cell has been a feasible method (17).  Even
though neither parent has the deletion, it is expected that
there will be a low risk of having a further child with a 22q11
deletion since gonadal mosaicism (18) cannot be ruled out (6).
In a series of 17 nonsyndromic children with congenital
conotruncal heart defects, five were found to have a 22q11
deletion (19). However, it is now well established that near-
ly all patients with the microdeletion exhibit subtle but
Fig. 1. Fluorescence in situ hybridization (FISH) study detecting a
chromosome 22q11 deletion with LSI DiGeorge/VCFS dual color
probe. The green signal shows control region with chromosome
22q13.3 and red signal is responsible for DiGeorge critical region.
Arrow head shows normal chromosome 22 with green and red
signals. Arrow indicated the chromosome 22 with only green sig-
nal, pointing to a deletion in chromosome.Prenatal Diagnosis of TOF with 22q11 Microdeletion 127
typical facial features (20, 21). The prevalence of the 22q11
microdeletion in newborn infants with congenital conotrun-
cal cardiac anomalies was reported to be about 48% (22).
They suggested that FISH should be performed in newborn
infants with conotruncal defect and at least one additional
manifestation of the CATCH 22 phenotype. The prevalence
of 22q11 deletion in tetralogy of Fallot patients was report-
ed to be 13% (23). These data from postnatal studies are not
applicable to prenatal diagnosis, since dysmorphic features
may not be accessible to ultrasound survey and every conotrun-
cal heart defect detected in the fetal period is potentially
related to the 22q11 microdeletion. Very few data are avail-
able concerning the prognosis for fetuses diagnosed prena-
tally as having a 22q11 deletion. Prenatal diagnosis of 22q11
deletion was reported in a fetus with a known affected sister
and father (24), in a fetus of a patient with the deletion and
velocardiofacial syndrome (13), in a fetus of a mother with
congenital heart disease (25), and in a fetus with interrupt-
ed aortic arch type B (26). The discovery of a conotruncal
heart defect associated with a 22q11 deletion during preg-
nancy might indicate a severe form of this syndrome, which
is known to show a great phenotypic variability.
Whether molecular cytogenetic studies should be offered
when a conotruncal heart defect is diagnosed during fetal life
remains controversial. Among the pregnancies with prena-
tally detected heart defect, about 11.5% of the cases have the
deletion (5). According to the increasing awareness among
obstetricians, echocardiographists and geneticists, one can
predict that there will be a dramatic increase in demand for
prenatal diagnosis of 22q11 deletion. Prenatal detection
allows time for genetic counseling. It is also helpful in mak-
ing choices and arrangements for delivery and postnatal sur-
gical care, planning the immediate neonatal medical care,
detecting other affected family members, and considering a
cesarean section in case of fetal distress. These discussions and
decisions are difficult when the diagnosis of a major anoma-
ly requiring emergency care is established after birth.
These findings highlight the importance of performing
FISH for suspected chromosome 22q11 deletion during
pregnancy when ultrasound studies show a conotruncal car-
diac anomaly. However, the counseling remains difficult in
view of the clinical variability described in DGS, where the
phenotype cannot be accurately predicted from the genotype.
In our opinion, the knowledge of the fetal status with regard
to the 22q11 microdeletion remains useful. It could help the
decision making process of obstetricians, pediatric cardiolo-
gists, and surgeons in the perinatal period. In conclusion,
prenatally detected tetralogy of Fallot may be considered for
22q11 microdeletion.
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